Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
EDIT

Editas Medicine

$32.55

-0.64 (-1.93%)

07:45
09/21/18
09/21
07:45
09/21/18
07:45
Initiation
Editas Medicine initiated at Raymond James »

Editas Medicine initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRSP

Crispr Therapeutics

$48.90

-3 (-5.78%)

07:45
09/21/18
09/21
07:45
09/21/18
07:45
Initiation
Crispr Therapeutics initiated at Raymond James »

Crispr initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 21

    Sep

NTLA

Intellia Therapeutics

$31.50

-0.48 (-1.50%)

07:44
09/21/18
09/21
07:44
09/21/18
07:44
Initiation
Intellia Therapeutics initiated at Raymond James »

Intellia Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

Thursday
CRSP

Crispr Therapeutics

$48.90

-3 (-5.78%)

21:25
09/20/18
09/20
21:25
09/20/18
21:25
Syndicate
Crispr Therapeutics 4.211M share Secondary priced at $47.50 »

Goldman Sachs, Piper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 21

    Sep

CRSP

Crispr Therapeutics

$48.90

-3 (-5.78%)

16:44
09/20/18
09/20
16:44
09/20/18
16:44
Initiation
Crispr Therapeutics initiated at Raymond James »

Crispr Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 21

    Sep

NTLA

Intellia Therapeutics

$31.50

-0.48 (-1.50%)

16:44
09/20/18
09/20
16:44
09/20/18
16:44
Initiation
Intellia Therapeutics initiated at Raymond James »

Intellia Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

EDIT

Editas Medicine

$32.55

-0.64 (-1.93%)

16:43
09/20/18
09/20
16:43
09/20/18
16:43
Initiation
Editas Medicine initiated at Raymond James »

Editas Medicine initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Wednesday
MLHR

Herman Miller

$37.30

0.2 (0.54%)

, LCI

Lannett

$4.85

0.15 (3.19%)

18:56
09/19/18
09/19
18:56
09/19/18
18:56
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Herman…

MLHR

Herman Miller

$37.30

0.2 (0.54%)

LCI

Lannett

$4.85

0.15 (3.19%)

AVP

Avon Products

$2.32

0.03 (1.31%)

NGD

New Gold

$1.10

0.03 (2.80%)

AMD

AMD

$31.20

-0.73 (-2.29%)

RHT

Red Hat

$143.38

0.59 (0.41%)

MTEM

Molecular Templates

$6.25

2.15 (52.44%)

CRSP

Crispr Therapeutics

$51.90

-1.27 (-2.39%)

KOS

Kosmos

$9.35

0.04 (0.43%)

VKTX

Viking Therapeutics

$19.64

0.17 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

  • 23

    Sep

  • 27

    Sep

  • 01

    Oct

  • 20

    Sep

  • 21

    Sep

  • 21

    Sep

  • 21

    Sep

CRSP

Crispr Therapeutics

$51.83

-1.34 (-2.52%)

16:09
09/19/18
09/19
16:09
09/19/18
16:09
Syndicate
Crispr Therapeutics files to sell $200M in common stock »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

CRSP

Crispr Therapeutics

$51.77

-1.4 (-2.63%)

16:05
09/19/18
09/19
16:05
09/19/18
16:05
Syndicate
Breaking Syndicate news story on Crispr Therapeutics »

Crispr Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.